Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2010 June;62(3) > Minerva Ginecologica 2010 June;62(3):213-23

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  REPRODUCTIVE MEDICINE - PART II


Minerva Ginecologica 2010 June;62(3):213-23

language: English

Preimplantation genetic diagnosis

Lalioti M. D.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA


PDF  


Preimplantation genetic diagnosis (PGD) is the screening of embryos at the cleavage stage in order to select and transfer only the desired embryo. The main indications of PGD are monogenic disorders and aneuploidy. This article reviews the recent advances in PGD methodology and presents their advantages, disadvantages and challenges. Ethical considerations arising with more widespread use of PGD for physical traits is also discussed. PGD for monogenic disorders remains the most successful indication, but is technically more challenging. PGS for aneuploidy has passed through a period of reconsideration and is now re-emerging with complete genome screening.

top of page

Publication History

Cite this article as

Corresponding author e-mail

maria.lalioti@yale.edu